High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas.
Bitran
J D
JD
Department of Medicine, Pritzker School of Medicine, University of Chicago, IL.
Williams
S F
SF
Moormeier
J
J
Mick
R
R
D000328:Adult; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006689:Hodgkin Disease / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008223:Lymphoma / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D015996:Survival Rate; D013852:Thiotepa / Q000009:adverse effects / Q000627:therapeutic use*
D013852:Thiotepa